Arcturus Therapeutics Secures $50 Million Investment From Meiji Seika Pharma
Arcturus Therapeutics said it secured a $50 million investment from Meiji Seika Pharma in an expanded collaboration.
Arcturus Therapeutics said it secured a $50 million investment from Meiji Seika Pharma in an expanded collaboration.